Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tyrosine kinase inhibitor
Most Correlated Studies
- Dermal fibroblasts treated with the tyrosine kinase inhibitor erlotinib
- Kit225 human leukemia cells treated with NC1153 JAK3 tyrosine kinase inhibitor
- Lung cancer PC9 cells with tolerance or sensitivity to EGFR tyrosine kinase inhibitor gefitinib
- A375, A549, H3122, PC-9, NCI-N87 and RT-112 cells treated with THZ1 and/or tyrosine kinase inhibitor
- Left ventricle of high fat diet-fed ApoE KO mice treated with tyrosine kinase inhibitor ponatinib
Most Relevant Literature
- Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatm…
- JAK2 inhibitors for the treatment of Philadelphia-negative myeloproliferative neoplasms: current sta…
- Identification and validation of the association of Janus kinase 2 mutations with the response to im…
- Advances in the design and discovery of next-generation janus kinase-2 (JAK2) inhibitors for the tre…
- The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protei…
Most Relevant Clinical Trials
- A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
- Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
- A Study for Tyrosine Kinase Inhibitors Discontinuation
- Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor
- Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility
